Newsletter

Ujjwal Maheshwari

Ujjwal Maheshwari is a Sydney-based financial writer at Stocks Down Under, where he has covered ASX and forex markets for over three years. He specialises in breaking down complex market developments into clear, accessible analysis for everyday investors.

Bachelor of Commerce (Finance), University of New South Wales (UNSW)

728 articles published

Market news

Why the ASX 200 Just Hit a 7-Week Low: Global Bond Yields Explained

The ASX 200 dropped to a fresh 7-week low on Wednesday, closing down 1.26% at 8,496.6, a fall of 108 points on the day. The index is now down roughly 5% over the past month. With banks and miners both sinking and the selling spread across most of the market, this looks less like a…

ByUjjwal MaheshwariMay 20, 20260Comments

Lynas Rare Earths ASX LYC share price chart showing 4.3% fall as rare earth rally cools

Mining Stocks Rare Earths Stocks

Lynas Rare Earths (ASX:LYC) Drops 4% as China-US Truce Cools the Rare Earth Rally. Time to Take Profit?

Lynas Rare Earths (ASX:LYC) fell 4.3% on Tuesday to close at A$18.12, with no bad news from the company itself. The selling looked like classic profit-taking after a remarkable run. Even after the pullback, Lynas is still up around 48% for the year, making it one of the standout performers on the ASX in 2026.…

ByUjjwal MaheshwariMay 20, 20260Comments

Tech Stocks

TechnologyOne (ASX:TNE) Shares Fell 4% Today Despite Record Profit. Buy the Dip or Wait?

TechnologyOne Falls Despite Record Profit TechnologyOne (ASX:TNE) slipped almost 4% today, even after handing in its 17th record first-half profit in a row. Annual recurring revenue, the lifeblood of any software business, grew 17%, and the UK business, TNE's biggest growth engine, jumped 23%. On paper, that sounds like a result worth celebrating. So why…

ByUjjwal MaheshwariMay 19, 20260Comments

Coal Stocks Mining Stocks

New Hope (ASX:NHC) Charges Higher on Q3 Results: Why Coal Is the Surprise Winner of 2026

New Hope Rises on Strong Q3 Result New Hope Corporation (ASX:NHC) shares pushed higher on Monday, testing intraday highs of A$5.32 after the coal miner delivered a strong Q3 FY26 result. Underlying EBITDA jumped 21.7% to A$130.1 million as the company sold more coal at slightly higher prices. While most investors have spent 2026 chasing…

ByUjjwal MaheshwariMay 19, 20260Comments

AI Stocks

NVIDIA (NASDAQ: NVDA) Reports Wednesday: 5 ASX Stocks That Will Move on the Result

NVIDIA (NASDAQ: NVDA) reports its latest quarterly numbers after the US market closes on Wednesday, 20 May, which is Thursday morning here in Australia. The world's most-watched chip company sells the powerful GPUs that companies like Microsoft, Amazon and Google use to run their artificial intelligence systems. Last quarter, NVIDIA's data centre business alone brought…

ByUjjwal MaheshwariMay 19, 20260Comments

Industrials

ALS Limited (ASX:ALQ) Falls Despite Record FY26 Profit: Buy the Dip or Wait?

ALS Limited Falls Despite Record FY26 Profit ALS Limited (ASX: ALQ) shares slipped 1.7% on Monday to close at A$21.83, even after the lab testing giant reported the strongest year in its history. Revenue climbed 10.7% to A$3.32 billion and underlying profit jumped 25.8% to A$381.2 million, with the company also paying down debt. So…

ByUjjwal MaheshwariMay 18, 20260Comments

Healthcare Stocks

Pro Medicus (ASX:PME) Wins A$90m Beth Israel Lahey Deal: Buy the Dip or Wait After 56% Crash?

Pro Medicus Wins A$90m Beth Israel Lahey Deal Pro Medicus (ASX:PME) has landed another major US contract, signing a seven-year, A$90m deal with Beth Israel Lahey Health, a Boston-based hospital network. The contract will see Pro Medicus roll out its cloud-based Visage 7 imaging platform across 14 hospitals in Massachusetts and New Hampshire, with the…

ByUjjwal MaheshwariMay 18, 20260Comments

Market news

Tax Loss Selling Season Is Coming: 7 Beaten-Down ASX Stocks Most Likely to Get Dumped Before June 30

ASX Stocks Most Exposed Before June 30 Every June, billions of dollars get sold on the ASX for tax reasons rather than business reasons. With the Australian financial year ending June 30, investors are clearly losing positions to offset gains taken elsewhere. The pressure usually peaks in the final two weeks before EOFY, pushing already-weak…

ByUjjwal MaheshwariMay 18, 20260Comments

Healthcare Stocks

Racura Oncology (ASX:RAC) Surges 8% as RC220 Trial Cleared to Double Dosage Level

Racura Oncology Surges on Trial Update Racura Oncology (ASX: RAC) climbed 8.66 per cent on Friday to close at A$2.76, after the independent Safety Review Committee cleared the company to double the dosage level in its CPACS Phase 1 cancer trial. The first three patients in Cohort 1 showed no dose-limiting toxicities and remain alive…

ByUjjwal MaheshwariMay 18, 20260Comments

Nvidia chip with ASX stocks chart after record quarterly result

Market news

ASX Week in Review: Budget Shock, DroneShield Crisis and the AI Bubble Question

ASX 200 Falls as Budget and DRO Hit Market The S&P/ASX 200 closed Friday at 8,630.80, down 1.3% for the week and sitting at a five-week low. It was a choppy week pulled in three directions. The Federal Budget rewrote the rules on capital gains tax. DroneShield got hit with an ASIC probe. And on…

ByUjjwal MaheshwariMay 16, 20260Comments

the Kick-ass Multipurpose WordPress Theme

Ujjwal Maheshwari

Why the ASX 200 Just Hit a 7-Week Low: Global Bond Yields Explained

Lynas Rare Earths (ASX:LYC) Drops 4% as China-US Truce Cools the Rare Earth Rally. Time to Take Profit?

TechnologyOne (ASX:TNE) Shares Fell 4% Today Despite Record Profit. Buy the Dip or Wait?

New Hope (ASX:NHC) Charges Higher on Q3 Results: Why Coal Is the Surprise Winner of 2026

NVIDIA (NASDAQ: NVDA) Reports Wednesday: 5 ASX Stocks That Will Move on the Result

ALS Limited (ASX:ALQ) Falls Despite Record FY26 Profit: Buy the Dip or Wait?

Pro Medicus (ASX:PME) Wins A$90m Beth Israel Lahey Deal: Buy the Dip or Wait After 56% Crash?

Tax Loss Selling Season Is Coming: 7 Beaten-Down ASX Stocks Most Likely to Get Dumped Before June 30

Racura Oncology (ASX:RAC) Surges 8% as RC220 Trial Cleared to Double Dosage Level

ASX Week in Review: Budget Shock, DroneShield Crisis and the AI Bubble Question

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Ujjwal Maheshwari

Stocks in Spotlight

Add Your Heading Text Here